Agenda

Expand All +
  • Day 1

    May 10, 2022

  • Day 2

    May 11, 2022

  • In this keynote conversation, Frank Doyle, a pioneer in the development of the artificial pancreas, will share his insights on the future of medical device development including the expanding role of robotics and artificial intelligence.

    Doyle will hit upon several critical areas:

    · Lessons learned from the many years spent developing the complicated systems and algorithms of an artificial pancreas and providing the support necessary to bring it to market.
    · How he’s working to solidify SEAS’s position as a partner for industry and developer of the next generation of innovators.
    · Where he sees medical device innovation benefiting from increased cooperation between engineering, business, and medical schools as well as hospitals, foundations and the government.
    · What the medical device industry can learn from - and teach to - leaders in the technology industry.
    Keynotes
    Product Development & Prototyping

  • Venture capitalists – like everyone else – were forced to pivot to avoid the roadblocks brought on by the pandemic. Pivots – by their nature – force us into new directions. So how have venture capitalists adopted the changes required for investing the past two years? What new models and measurements are being employed when backing medical device companies.
    Innovation & Investment
    Keynotes
    Panels

  • The past two years significantly changed how VC investors identified new technologies to support. In this panel, investors from institutional and strategic funds will detail their plans going forward.

  • MedTech Innovator, the largest life sciences accelerator in the world, brings its 2022 roadshow to DeviceTalks Boston. Two dozen highly vetted mid- to late-stage privately held medical device companies out of more than 1,000 applicants will share their stories in hopes of finding the investors and partners who will enable them to get their products to market.
    Innovation & Investment

  • Pulsed-field ablation (PFA), a non-thermal method for cardiac ablation, promises to upend the atrial fibrillation market. In this panel, representatives from the industry leaders will detail what the new technology means for innovation and for atrial fibrillation patients.
    Panels
    Product Development & Prototyping

  • Medical device makers faced unprecedented challenges in securing materials and supplies over the past two years. In this discussion, supply chain leaders will detail the challenges, share insights they gained and share their outlook for the future.
    Manufacturing & Markets
    Panels

  • Hospitals need more connectivity then every before. In this discussion, we'll hear how medical device companies are rising to build the tools necessary to keep operating rooms running smoothly and patients getting the care they need.
    Digital Tools & Data
    Panels

  • Medical device start-ups who don't get their IP right from the start may end up paying for it down the road. In this panel sponsored by Finnegan will collect insights and experiences from successful investors.
    Innovation & Investment
    Panels

  • With today’s ever changing needs and demands for getting product to market as quickly as possible, the industry is demanding prototypes to be developed at rapid speeds. The challenge is that often these ‘rapid prototypes’ do not yield comparable properties to final, finished, form devices and products. What can appear to be a significant savings to the initial project timeline, often results in significant delays on the back end of the project- managing unintended and often irrelevant challenges to the project. Increasing regulatory pressures on medical device OEMs is driving the need for those OEMs to develop real, applicable, functional parts that can properly identify real and potential failure modes for which to mitigated. Tools developed in days, 3D printing, or machined products, while seemingly attractive from a timeline perspective, often do not account for key attributes of polymer products such as orientation effects or residual stresses, which can be critical to quality for a medical device. The intent of this talk is to review today’s most common forms of developing prototypes during the product development process and highlight challenges and opportunities along the way.
    Panels
    Product Development & Prototyping

  • An influx in supply chain issues over the past 2 years has greatly impacted the speed at which companies are able to launch new products and has prompted manufacturers to take a look at enhancing the speed and readiness of their supply chains, and in many instances pivoting to increased digitization. This paradigm shift is happening in MedTech today as the industry is evolving to adopt 3D printing technology beyond prototyping and into mass production. Hosted and moderated by 3DEO President Matt Sand, this panel discussion will explore accelerating speed to market with an emphasis on supply chain efficiencies in MedTech.
    Manufacturing & Markets
    Panels

  • MedTech Innovator, the largest life sciences accelerator in the world, brings its 2022 roadshow to DeviceTalks Boston. Two dozen highly vetted mid- to late-stage privately held medical device companies out of more than 1,000 applicants will share their stories in hopes of finding the investors and partners who will enable them to get their products to market.
    Innovation & Investment

  • The HeartMate 3 LVAD with Full MagLev™ Flow Technology has significantly advanced the field of LVAD therapy, setting the standard with innovation and outstanding clinical outcomes that make a meaningful difference in patients lives. But what's next for this life-saving device. In this panel, Abbott engineers, professionals and a surgeon will recount the LVAD's past success and potential for the future.
    Product Development & Prototyping

  • Senior leaders from DePuy Synthes will discuss the company is changing its product development process, setting up the supply chain for a MedTech organization, learning about regulatory and access requirements for a digital solution, evolving our commercialization plans and using technology to amplify the effectiveness and reach of our education solutions. Key part of this journey is also how we are evolving the culture of the organization and leaning into DE&I.
    Manufacturing & Markets

  • Learn what to do and what NOT to do from a panel of experts who have been through M&A battles and closed headline grabbing medtech deals. Leading patent attorney David Dykeman who co-chairs the Global Life Sciences & Medical Technology Group at international law firm Greenberg Traurig will lead a panel of medtech industry executives to discuss positioning IP for M&A success.
    Innovation & Investment

  • Ask questions and learn more about the importance of strategy and culture when choosing an outsource partner. Hear how Viant and Vapotherm used this collective mindset to achieve a manufacturing transfer in record time. Together, with a shared vision, these two organizations were able to increase capacity quickly, meet skyrocketing demand, and ultimately better serve patients and providers. We’ll discuss key considerations when determining how outsourcing can support your organization’s strategic needs, best practices for choosing an outsource partner, and how strategy and culture played a role in helping both Viant and Vapotherm creatively solve a supply chain challenge, support customers and provide access to a critical therapy.
    Manufacturing & Markets
    Panels

  • Stryker has been on a journey to improve outcomes through digital technology for decades. Today, the company is accelerating its delivery of these technologies through organic innovation and M&A. This panel will discuss industry trends, breakthrough technologies and what a heightened focus on digital might mean for MedTech.
    Digital Tools & Data

  • Insulet is a leader in the race to help people with diabetes live more comfortably. Just this year, the company received FDA approval for its Omnipod 5, the first tubeless, wearable, automated insulin delivery system. In this interview, Petrovic will discuss the work that went into this significant device and shed some light on where Insulet - and diabetes management - is headed.
    Keynotes

  • Hear how medical device companies are moving to ensure clinical trials do a better job of representing the broader patient base. What's being done? What still needs to be done to create trials that measure the efficacy of new devices more effectively.
    Regulatory, Reimbursement & Policy

  • Corindus, A Siemens Healthineers Company, is leading the way with developing technology to deliver remote robotic care. Engineering teams faced many challenges during development, not only technically, but also in usability and workflow. Some of these hurdles included connectivity bandwidth and latencies, image quality, communication between remote operators and local hospital staff, and human factors engineering. Join our R&D and product management experts to learn how they are approaching and overcoming these challenges to deliver a new paradigm of patient care.
    Product Development & Prototyping

  • MedTech Innovator, the largest life sciences accelerator in the world, brings its 2022 roadshow to DeviceTalks Boston. Two dozen highly vetted mid- to late-stage privately held medical device companies out of more than 1,000 applicants will share their stories in hopes of finding the investors and partners who will enable them to get their products to market.
    Innovation & Investment

  • In this session, Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, will sit down with Jenny Lee, vice president, corporate digital and patient & referrer marketing, to break down how company engineers leverage voice of the customers (VOC) to advance meaningful innovation.
    Product Development & Prototyping

  • We plan to provide conference attendees with a survey of top regulatory and practical challenges facing medtech companies in pursuit of coverage, payment, and market access. We will explore the current regulatory landscape facing medtech companies in interacting with government payors, including how potential regulatory shifts will impact the bottom line. We will also examine other key considerations, including building a case for payment, identifying the best proof to support coverage and payment, and ensuring appropriate provider participation in the process, among other topics. And of increasing importance, we will discuss thinking outside of the traditional “beltway” focus and examining private payor concerns. We hope to do so in a dynamic, speed round format.

  • In this conversation, Tracy Accardi, vice president of R&D, surgical robotics, and Mike Stow, vice president of marketing, surgical robotics, will examine Hugo’s past and lay out its future path.
    Product Development & Prototyping

  • In this keynote session, four highly vetted mid-stage medtech companies selected from over 1,000 applicants will compete for a cash prize and a coveted admission to MedTech Innovator, the largest medical technology accelerator in the world. Each will present their pitch to a panel of industry judges and the DeviceTalks audience. Ultimately, the DeviceTalks audience will vote for the winner who will receive a cash prize towards their travel to present in upcoming MedTech Innovator showcases at the Wilson Sonsini Medical Device conference in June and AdvaMed's The MedTech Conference in October.
    Innovation & Investment

Thanks for attending!

Thanks for joining us May 10-11 at the Boston Convention and Exhibition Center for the return of Devicetalks Boston!